Literature DB >> 29435387

Systemic Mastocytosis: The Difficult Patient with a Rare Disease. Case Presentation and Brief Review.

Daniel H Desmond1,2, Mark G Carmichael1,2.   

Abstract

Mastocytosis is a rare process involving the activation and accumulation of clonal mast cells categorized by cutaneous or systemic involvement. Although the diagnosis of cutaneous disease can be straightforward and confirmed via skin biopsy, systemic disease mimics more common disease processes making diagnosis a challenge. The widespread physiologic distribution of mast cells causes a variety of symptoms with aberrant expression including fatigue, headache, depression, dyspnea, dyspepsia, nausea, and abdominal pain. We present a patient with a three-year history of multiple, non-specific complaints prompting extensive evaluation at significant financial and emotional cost without therapeutic relief. This case presentation illustrates some of the pitfalls of evaluation and management of mastocytosis when symptoms are treated in isolation. Ultimately, our patient was diagnosed with indolent systemic mastocytosis (ISM), which has a good overall prognosis but no curative treatment. Providers must maintain a high index of suspicion for mastocytosis in order to make the diagnosis and facilitate appropriate treatment and screening.

Entities:  

Keywords:  Mastocytosis; c-KIT; urticaria

Mesh:

Year:  2018        PMID: 29435387      PMCID: PMC5801525     

Source DB:  PubMed          Journal:  Hawaii J Med Public Health        ISSN: 2165-8242


  9 in total

1.  Mast Cells, Mastocytosis, and Related Disorders.

Authors:  Theoharis C Theoharides; Peter Valent; Cem Akin
Journal:  N Engl J Med       Date:  2015-11-05       Impact factor: 91.245

Review 2.  Systemic mastocytosis involving the gastrointestinal tract: case report and review.

Authors:  Amir Behdad; Scott R Owens
Journal:  Arch Pathol Lab Med       Date:  2013-09       Impact factor: 5.534

3.  Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis.

Authors:  Jason Gotlib; Hanneke C Kluin-Nelemans; Tracy I George; Cem Akin; Karl Sotlar; Olivier Hermine; Farrukh T Awan; Elizabeth Hexner; Michael J Mauro; David W Sternberg; Matthieu Villeneuve; Alice Huntsman Labed; Eric J Stanek; Karin Hartmann; Hans-Peter Horny; Peter Valent; Andreas Reiter
Journal:  N Engl J Med       Date:  2016-06-30       Impact factor: 91.245

Review 4.  Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria.

Authors:  Peter Valent; Cem Akin; Wolfgang R Sperr; Luis Escribano; Michel Arock; Hans-Peter Horny; John M Bennett; Dean D Metcalfe
Journal:  Leuk Res       Date:  2003-07       Impact factor: 3.156

Review 5.  Neuropsychological features of adult mastocytosis.

Authors:  Daniela S Moura; Sophie Georgin-Lavialle; Raphaël Gaillard; Olivier Hermine
Journal:  Immunol Allergy Clin North Am       Date:  2014-05       Impact factor: 3.479

Review 6.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

Review 7.  Epidemiology, prognosis, and risk factors in mastocytosis.

Authors:  Knut Brockow
Journal:  Immunol Allergy Clin North Am       Date:  2014-05       Impact factor: 3.479

Review 8.  Functional deregulation of KIT: link to mast cell proliferative diseases and other neoplasms.

Authors:  Glenn Cruse; Dean D Metcalfe; Ana Olivera
Journal:  Immunol Allergy Clin North Am       Date:  2014-03-12       Impact factor: 3.479

Review 9.  Diagnosis and management of mastocytosis: an emerging challenge in applied hematology.

Authors:  Peter Valent
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2015
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.